1型糖尿病年轻患者感染SARS-CoV-2后的症状与血糖控制:一项观察性研究
以色列3家儿童糖尿病诊所于2020年3月中旬至2021年3月中旬开展观察性研究,纳入132例确诊SARS-CoV-2感染的1型糖尿病年轻患者(平均年龄16.9±5.3岁)。103例(78%)出现相关症状,均为轻症,4例需住院,2例与COVID-19直接相关。年龄、血糖升高和合并症与有症状感染正相关;16.5%的患者在中位6.7个月内出现持续症状。
要点
- 132例1型糖尿病年轻患者中103例(78%)有COVID-19相关症状,最常见为头痛、乏力、发热和嗅觉丧失。
- 年龄(OR=1.11)、血糖升高(OR=5.23)和合并症(OR=8.21)与有症状感染正相关。
- 16.5%的患者在中位6.7个月内出现持续症状,年龄(OR=1.14)和血糖升高(OR=3.42)与持续症状正相关。
核心结论
- 已确诊1型糖尿病的年轻患者感染COVID-19多为轻症,感染期间血糖升高和年龄较大与病程延长相关。
研究设计与样本
- 观察性研究,在以色列3家儿童糖尿病诊所开展,时间为2020年3月中旬至2021年3月中旬。
- 纳入已确诊1型糖尿病、年龄小于30岁、SARS-CoV-2核酸检测阳性的年轻患者,共132例,平均年龄16.9±5.3岁。
- 数据来自医疗档案、糖尿病设备和COVID-19问卷,按有无临床症状及年龄组(儿童<19岁/年轻成人19-30岁)分析。
主要发现
- 132例中103例(78%)有相关症状,最常见为头痛、乏力、发热和嗅觉丧失;所有患者均为轻症,4例需住院,2例与COVID-19感染直接相关(1例免疫缺陷综合征患者发生胸膜肺炎,1例糖尿病酮症酸中毒)。
- logistic回归分析显示,年龄(OR=1.11;95%CI 1.01-1.23;P=.033)、血糖升高(OR=5.23;95%CI 1.12-24.41;P=.035)和合并症(OR=8.21;95%CI 1.00-67.51;P=.050)与有症状感染正相关。
- 16.5%的患者在中位6.7个月内出现持续症状;年龄(OR=1.14;95%CI 1.01-1.29;P=.030)和血糖升高(OR=3.42;95%CI 1.12-10.40;P=.031)与持续症状正相关。
- 通常血糖水平无变化(64%),仅在短期感染期间出现血糖控制暂时性恶化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Data is needed regarding the effect of SARS-CoV-19 infection on young people with established type 1 diabetes. Identifying the disease outcomes, short and long-term sequelae may help to establish an evidence-based prevention and education policy for sick days management and DKA prevention. OBJECTIVE: This work aims to describe clinical manifestations of SARS-CoV-2 infection in children, adolescents, and young adults with established type 1 diabetes (T1D) and explore the effects of COVID-19 on glycemic control and disease course. METHODS: An observational study was conducted at 3 pediatric diabetes clinics in Israel between mid-March 2020 and mid-March 2021. Included were young people with established T1D, age younger than 30 years, who tested positive for SARS-CoV-2 (quantitative real-time polymerase chain reaction). Data were collected from medical files, diabetes devices, and COVID-19 questionnaire. Outcome measures were analyzed by the presence/absence of clinical symptoms (symptomatic/asymptomatic) and by age group (pediatric, < 19 years/young adults, 19-30 years). RESULTS: Of 132 patients, mean age 16.9 ± 5.3years, with COVID-19-confirmed infection, 103 (78%) had related symptoms; the most common were headaches, fatigue, fever, and loss of sense of smell. All had a mild disease course, but 4 required hospitalization and 2 cases were directly related to COVID-19 infection (pleuropneumonia in a patient with immunodeficiency syndrome, 1 case of diabetic ketoacidosis). Logistic regression analysis showed that age (odds ratio [OR] = 1.11; 95% CI, 1.01-1.23; P = .033), elevated glucose levels (OR = 5.23; 95% CI, 1.12-24.41; P = .035), and comorbidities (OR = 8.21; 95% CI, 1.00-67.51; P = .050) were positively associated with symptomatic infection. Persistent symptoms occurred in 16.5% of the cohort over a median of 6.7 months; age (OR = 1.14; 95% CI, 1.01-1.29; P = .030) and elevated glucose levels (OR = 3.42; 95% CI, 1.12-10.40; P = .031) were positively associated with persistent symptoms. Usually, no change was reported in glucose levels (64%) except for a temporary deterioration in glycemic control during the short infection period. CONCLUSION: Young people with established T1D experience mild COVID-19 infection. Elevated glucose levels during COVID-19 infection and older age were associated with prolonged disease course.
引用
- Nimri R, Rachmiel M, Yackobovitch-Gavan M, et al. Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational Study. J Clin Endocrinol Metab. 2022. PMID: 35524727. doi:10.1210/clinem/dgac288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。